GROWTH HORMONE FAMILY
GHRP-2
Synthetic growth hormone secretagogue hexapeptide. Investigated in GH-axis and ghrelin-receptor research.
Bundle & save
Free shipping
on orders over $300
Damage protection
replacement guarantee
Secure checkout
3D Secure
Certificate of Analysis
Third-party tested · ISO/IEC 17025 accredited
—
purity
✓ Passed full QC panel
- Variant
- GHRP-2 · 10 mg
- Lot #
- —
- Labeled
- 10 mg
- Tested
- —
Full QC panel
- Purity (HPLC)
- —
- Net Peptide Content
- Pass
- Identity (HPLC-MS)
- Confirmed
- Heavy Metals (ICP-MS)
- Not detected
- Sterility
- No growth
- Endotoxin (LAL)
- Within limits
Purity, lot and tested date are per-lot; remaining QC rows are representative — exact values on the CoA.
Compound Information
Chemical and structural properties
Chemical identity verified via NIH PubChem · biological targets characterized from the peer-reviewed literature.
Molecular profile
Structure
- CAS Number
- 158861-67-7
- Molecular Formula
- C45H55N9O6
- Molecular Weight
- 818 g/mol
- Sequence
- —
- Type
- Research peptide
- PubChem
- CID 6918245 ↗
Biological targets
Interactions
- Primary target
- Ghrelin receptor (GHS-R1a)
- Pathway
- GHS-R1a–Gq/PLC–Ca2+ signaling; pituitary GH release with modest ACTH / prolactin co-release
- Mechanism
- Synthetic hexapeptide growth-hormone secretagogue (pralmorelin); ghrelin-receptor agonist
- Research area
- Growth-hormone axis, pituitary-function testing research
Physical properties
Handling & Storage
- Appearance
- White to off-white lyophilized powder
- Solubility
- Soluble in sterile or bacteriostatic water; reconstitute prior to use
- Storage
- 2-8 deg C, protect from light
- Country of origin
- USA
Sources & References
Peer-reviewed research
Indexed in NIH PubMed. Provided for research context; not a claim of clinical outcome.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM : JPEM
Robust growth hormone responses to GH-releasing peptide 2 in adolescents
2024 · PMID 38958228
Onuki T et al.
View Source ↗DRUGS IN R&D
Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN
2004 · PMID 15230633
—
View Source ↗JOURNAL OF THE ENDOCRINE SOCIETY
Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder
2022 · PMID 35795807
Suzuki S et al.
View Source ↗JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM : JPEM
Growth hormone response to GH-releasing peptide-2 in children
2010 · PMID 20662346
Asakura Y et al.
View Source ↗ENDOCRINE JOURNAL
Evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas
2018 · PMID 29973439
Kageyama K et al.
View Source ↗
⚠ Important research notice
PRODUCTS ARE INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. Products should only be handled by licensed, qualified professionals. Products sold are not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.
All the research peptides you need, with the peace of mind at your fingertips.
Stay Connected with Aminologix
Be the first to receive exclusive discount codes, new product launches, special offers, educational content, research updates, and company news. No spam. Unsubscribe anytime.